Learning from mistakes in clinical practice guidelines: the case of perioperative β-blockade

被引：15
作者：
Neuman, Mark D. [1 ,2 ]
Bosk, Charles L. [1 ,2 ,3 ]
Fleisher, Lee A. [1 ,2 ]
机构：
[1] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA
[2] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA
来源：
BMJ QUALITY & SAFETY | 2014年 / 23卷 / 11期
关键词：
ACTIVATED PROTEIN-C; NONCARDIAC SURGERY; CARDIOVASCULAR EVALUATION; MYOCARDIAL-INFARCTION; CARDIAC EVENTS; AMERICAN-COLLEGE; GLUCOSE CONTROL; BLOCKERS; RISK; MORBIDITY;
D O I：
10.1136/bmjqs-2014-003114
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：957 / 964
页数：8
相关论文
共 71 条
  • [1] 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    Jacobs, Alice K.
    Smith, Sidney C., Jr.
    Anderson, Jeffrey L.
    Buller, Christopher E.
    Creager, Mark A.
    Ettinger, Steven M.
    Guyton, Robert A.
    Halperin, Jonathan L.
    Hochman, Judith S.
    Krumholz, Harlan M.
    Kushner, Frederick G.
    Lytle, Bruce W.
    Nishimura, Rick
    Page, Richard L.
    Stevenson, William G.
    Tarkington, Lynn G.
    Yancy, Clyde W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (22) : E13 - E118
  • [2] A COMPARISON OF RESULTS OF METAANALYSES OF RANDOMIZED CONTROL TRIALS AND RECOMMENDATIONS OF CLINICAL EXPERTS - TREATMENTS FOR MYOCARDIAL-INFARCTION
    ANTMAN, EM
    LAU, J
    KUPELNICK, B
    MOSTELLER, F
    CHALMERS, TC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (02): : 240 - 248
  • [3] β-blockers and reduction of cardiac events in noncardiac surgery -: Clinical applications
    Auerbach, AD
    Goldman, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (11): : 1445 - 1447
  • [4] β-blockers and reduction of cardiac events in noncardiac surgery -: Scientific review
    Auerbach, AD
    Goldman, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (11): : 1435 - 1444
  • [5] Avorn J., 2005, Powerful medicines: The benefits, risks, and costs of prescription drugs, DOI DOI 10.1200/JOP.2014.003194
  • [6] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [7] Potential benefits of the new Leapfrog standards: Effect of process and outcomes measures
    Birkmeyer, JD
    Dimick, JB
    [J]. SURGERY, 2004, 135 (06) : 569 - 575
  • [8] Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery
    Bouri, Sonia
    Shun-Shin, Matthew James
    Cole, Graham D.
    Mayet, Jamil
    Francis, Darrel P.
    [J]. HEART, 2014, 100 (06) : 456 - 464
  • [9] Bradford H., 2003, Health Affairs, pw3, DOI 10.1377/hlthaff.w3.283.
  • [10] Use Of Beta-Blockers During Aortic Aneurysm Repair: Bridging The Gap Between Evidence And Effective Practice
    Brooke, Benjamin S.
    Dominici, Francesca
    Makary, Martin A.
    Pronovost, Peter J.
    [J]. HEALTH AFFAIRS, 2009, 28 (04) : 1199 - 1209
12345678